Uppsala Monitoring Centre

Uppsala Monitoring Centre (UMC) is a scientific organisation based in Uppsala, Sweden, focused on advancing the science of pharmacovigilance and improving the safety of medicines and vaccines globally. UMC serves national regulatory authorities, health ministries, and the pharmaceutical industry, providing products, services, and expertise that support pharmacovigilance systems at all levels of maturity. UMC also works in close collaboration with the World Health Organization (WHO), supporting international drug monitoring efforts and helping build capacity and effectiveness in safety surveillance worldwide.

UMC's work spans the full lifecycle of medicine and vaccine safety information, from data capture and management through to analysis, standardisation, and global sharing. The organisation combines scientific research with technological development, with active work in areas such as data-driven discovery, artificial intelligence, and the expansion of data sources available to safety surveillance.

Solutions for National Authorities

• Specialised products and services designed to support national pharmacovigilance systems across all levels of maturity
• Tools and training that streamline pharmacovigilance workflows for regulators and national health authorities
• Support for the full range of pharmacovigilance activities, including data capture, data management, signal analysis, and information sharing
• Capacity-building support delivered in partnership with the WHO Programme for International Drug Monitoring

Solutions for the Pharmaceutical Industry

• Standardised terminology and data exchange formats to support efficiency and interoperability across the pharmaceutical industry
• WHODrug Global, UMC's drug dictionary, used to standardise drug information across pharmacovigilance and clinical data systems
• Support for the development and adoption of IDMP (Identification of Medicinal Products) global identifiers
• Embracing and contributing to the development of global pharmacovigilance standards

Scientific Research and Innovation

• UMC operates as a research centre for pharmacovigilance and data science, with a long-term commitment to scientific development and collaboration
• Active research in data-driven discovery and the application of artificial intelligence to pharmacovigilance
• Work to expand the range of data sources available for safety surveillance
• Publication of scientific findings and educational content, including articles and podcasts covering topics such as disproportionality analysis, complementary medicines safety, and medical device vigilance
• Collaboration with national institutions, such as Instituto Butantan in Brazil, to embed standardised drug dictionaries into national pharmacovigilance systems

Through its combination of scientific expertise, standardisation work, and technology development, UMC supports regulators, health authorities, and industry partners in making medicines and vaccines safer for populations worldwide.